• After the Covid pandemic, we have resumed stem cell treatments. Appropriate sterility and great care in sanitisation is undertaken as usual. If you are unwell with a cough cold or respiratory symptoms it is best to postpone your procedure.

Adult human mesenchymal cells proliferate and migrate in response to chemokines expressed in demyelination.

150 150 NZ Stem Cell Treatment Centre

Cell Adh Migr. 2010 Apr-Jun;4(2):235-40
Adult human mesenchymal cells proliferate and migrate in response to chemokines expressed in demyelination.

Rice CM, Scolding NJ

Abstract
Systemic delivery of multipotent mesenchymal stem cells (MSC) may be of benefit in the treatment of neurological diseases, including multiple sclerosis (MS). Certainly, animal studies have demonstrated functional benefits following MSC transplantation, although the mechanisms by which MSCs migrate to lesions and stimulate repair remain unknown. Chemokines stimulate migration in other settings. In this study, we systematically explore the migratory and proliferative responses of human MSCs (hMSC) to chemokines expressed in MS lesions. We demonstrate that these chemokines trigger hMSC migration. In addition, we show that RANTES and IP-10 promote hMSC proliferation.

PMID: 20234187 [PubMed – in process]